Somatropin - Ferring

Drug Profile

Somatropin - Ferring

Alternative Names: Tev-Tropin; TevTropin; ZOMACTON; Zomacton

Latest Information Update: 14 Oct 2017

Price : *
* Final gross price and currency may vary according to local VAT and billing address.

At a glance

  • Originator Savient Pharmaceuticals
  • Developer Elvetium; Ferring Pharmaceuticals; Teva Pharmaceuticals USA
  • Class Growth hormones; Hormonal replacements
  • Mechanism of Action Somatotropin receptor agonists
  • Orphan Drug Status

    Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.

  • New Molecular Entity No

Highest Development Phases

  • Marketed Short stature; Somatotropin deficiency
  • Discontinued Cachexia

Most Recent Events

  • 10 Oct 2017 Ferring Pharmaceuticals entered into an asset purchase agreement to acquire worldwide rights to somatotropin
  • 31 Mar 2015 The FDA approves name change to ZOMACTON for Somatotropin deficiency in USA
  • 04 Mar 2015 Registered for Somatotropin deficiency in USA (SC, 10mg)
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at so we can help.

Back to top